Novo shares plummet on sales, profit warning for '26 as 2 top execs head for the doors

Wed, 04 Feb 2026 06:36:50 +0000
World

During the first six months of Maziar Mike Doustdar's tenure as Novo Nordisk's CEO, the company enjoyed a run of positive momentum highlighted by the launch of its Wegovy pill and a recent stock-price runup. But investor optimism came to a sudden halt Tuesday as the company warned of significant…